Neurocrine Biosciences
NBIX
$135.13
Share price
1.25%
Change (1 day)
-8.36%
Change (1 year)
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.
Cost to borrow NBIX shares - Neurocrine Biosciences
Latest borrow fee for Neurocrine Biosciences (NBIX) shares on Interactive Brokers: 0.2999% (annualized)
Shares available to borrow: 2000000The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.
Neurocrine Biosciences (NBIX) - cost to borrow in the last 7 days chart
Neurocrine Biosciences (NBIX) - number of shares available to borrow in the last 7 days
Neurocrine Biosciences (NBIX) - cost to borrow from 2025 to 2023
Neurocrine Biosciences (NBIX) - number of shares available to borrow from 2025 to 2023
Cost to borrow for shares of similar companies or competitors
| Company | Cost to borrow (% year) | Shares available | Country |
|---|---|---|---|
 Repligen
RGEN | 0.4081% | 0.65 M | 🇺🇸 USA |
 Royalty Pharma RPRX | 0.25% | 3.6 M | 🇬🇧 UK |
 Palatin Technologies PTN | 37.1567% | 0.4 M | 🇺🇸 USA |
 Eli Lilly LLY | 0.4081% | 2.9 M | 🇺🇸 USA |
 AbbVie ABBV | 0.25% | 7 M | 🇺🇸 USA |
 Pfizer PFE | 0.25% | 10 M | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | 0.25% | 0.3 M | 🇺🇸 USA |
 Athersys ATHX | 29.7439% | 1.6 M | 🇺🇸 USA |